Literature DB >> 2504863

Eicosanoid metabolism in cholesterol-enriched arterial smooth muscle cells: reduced arachidonate release with concomitant decrease in cyclooxygenase products.

K B Pomerantz1, D P Hajjar.   

Abstract

A biochemical correlation between vascular cholesterol metabolism and eicosanoid biosynthesis has not been fully elucidated. To assess the effects of cholesteryl ester (CE) accretion on eicosanoid synthesis, we studied eicosanoid metabolism in cultured rabbit aortic smooth muscle cells (SMC) following lipid-enrichment by incubation with cationized LDL (cLDL). SMC exposed to cLDL synthesized 50% less immunoreactive 6-keto-PGF1 alpha than untreated cells when exposed to the calcium ionophore, A-23187. In addition, cLDL-treatment reduced arachidonate acid (AA)-induced prostacyclin (PGI2) production sevenfold. Components of cLDL decreased eicosanoid biosynthesis in the following rank-order: linoleate greater than cholesterol greater than apo-cLDL. Lipid-enriched cells incorporated amounts of [1-14C]AA into phosphatidylcholine and phosphatidylethanolamine equal to control cells, but subsequent exposure to ionophore released significantly less radioactivity as free arachidonate (AA), with proportionally less conversion to eicosanoids. Ionophore released equivalent amounts of AA from all phospholipids, suggesting specificity for uptake, but not release of AA by cellular phospholipases. Cells enriched in CE had an eightfold decrease in percentage of phospholipid-derived AA relative to linoleate as compared to controls. Taken together, our data demonstrate that SMC metabolism of cLDL leads to cholesterol and CE accretion concomitant with diminished production of eicosanoids. Potential mechanisms for this effect include competitive inhibition of eicosanoid production by linoleate derived from LDL, direct inhibition of phospholipase A2 activity by cholesterol, and decrease in cyclooxygenase activity. These findings may have pathophysiological significance in that a reduction in PGI2 synthetic capacity of arterial SMC may exacerbate CE deposition since PGI2 promotes intracellular CE hydrolysis.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2504863

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  9 in total

1.  Marked alteration of proteoglycan metabolism in cholesterol-enriched human arterial smooth muscle cells.

Authors:  P Vijayagopal; J E Figueroa; Q Guo; J D Fontenot; Z Tao
Journal:  Biochem J       Date:  1996-05-01       Impact factor: 3.857

2.  Analysis of the physical state of cholesteryl esters in arterial-smooth-muscle-derived foam cells by differential scanning calorimetry.

Authors:  D P Hajjar; K B Pomerantz; J W Snow
Journal:  Biochem J       Date:  1990-06-15       Impact factor: 3.857

3.  In vitro infection of smooth muscle cells by Chlamydia pneumoniae.

Authors:  E Knoebel; P Vijayagopal; J E Figueroa; D H Martin
Journal:  Infect Immun       Date:  1997-02       Impact factor: 3.441

4.  Cholesterol loading reprograms the microRNA-143/145-myocardin axis to convert aortic smooth muscle cells to a dysfunctional macrophage-like phenotype.

Authors:  Yuliya Vengrenyuk; Hitoo Nishi; Xiaochun Long; Mireille Ouimet; Nazir Savji; Fernando O Martinez; Courtney P Cassella; Kathryn J Moore; Stephen A Ramsey; Joseph M Miano; Edward A Fisher
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-01-08       Impact factor: 8.311

5.  Inhibition of cholesterol esterification in macrophages and vascular smooth muscle foam cells: evaluation of E5324, an acyl-CoA cholesterol acyltransferase inhibitor.

Authors:  A C Nicholson; K B Pomerantz; T Fujimori; D P Hajjar
Journal:  Lipids       Date:  1995-08       Impact factor: 1.880

6.  Atherogenic concentrations of low-density lipoprotein enhance endothelial cell generation of epoxyeicosatrienoic acid products.

Authors:  K A Pritchard; P Y Wong; M B Stemerman
Journal:  Am J Pathol       Date:  1990-06       Impact factor: 4.307

7.  Enhanced synthesis and accumulation of proteoglycans in cholesterol-enriched arterial smooth muscle cells.

Authors:  P Vijayagopal
Journal:  Biochem J       Date:  1993-09-01       Impact factor: 3.857

8.  Transdifferentiation of mouse aortic smooth muscle cells to a macrophage-like state after cholesterol loading.

Authors:  James X Rong; Mark Shapiro; Eugene Trogan; Edward A Fisher
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-27       Impact factor: 11.205

9.  Decrease of prostaglandin E2 and 5-bromo-2'-deoxyuridine labeling but not prostate tumor development by indomethacin treatment of rats given 3,2'-dimethyl-4-aminobiphenyl and testosterone propionate.

Authors:  M Kawabe; M A Shibata; M Sano; Y Takesada; S Tamano; N Ito; T Shirai
Journal:  Jpn J Cancer Res       Date:  1997-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.